Major Study Links Common Dementia Drug to Stroke Risk in All Patient Groups
UK study of 165,000 dementia patients finds risperidone increases stroke risk across all groups, challenging safety assumptions.
Parkinson's disease, dopamine pathways, movement disorders, and neuroprotection
109 articles
UK study of 165,000 dementia patients finds risperidone increases stroke risk across all groups, challenging safety assumptions.
New research reveals how tiny plastic particles we consume daily could damage brain cells through five key biological pathways.
UCLA research links chlorpyrifos pesticide exposure to 2.5x higher Parkinson's risk by damaging brain's protein cleanup system.
New research reveals ADHD brains slip into brief sleep-like episodes during waking hours, explaining attention lapses and slower reactions.
New research reveals depression often appears years before Parkinson's or dementia diagnosis, suggesting it reflects early brain changes.
Major study identifies three existing drugs that could be repurposed to fight Alzheimer's disease, offering faster path to treatment.
18-month trial tested omega-3 supplementation in 774 older adults with low DHA/EPA levels and memory concerns to prevent cognitive decline.
Italian researchers investigated whether intensive exercise could slow Parkinson's progression by reducing inflammation and boosting protective factors.
Systematic review reveals lithium may slow amyloid buildup and tau protein damage in Alzheimer's disease models.
New research reveals capsaicin from chili peppers improves brain health by altering gut bacteria and cholesterol metabolism.
New research reveals how age-related brain changes amplify Parkinson's motor and cognitive symptoms independently of dopamine dysfunction.
Tavapadon, a once-daily oral medication, significantly improved motor function in early Parkinson's patients with fewer side effects.